Forest Hills Lab
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients. (NCT05931484) | Forest Hills Lab | 2027-11-01 |
| Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects (NCT05938452) | Forest Hills Lab | 2022-12-12 |
Track Forest Hills Lab automatically
Every clearance here is in the API, with alerts when new ones post.